HAUS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.806600E-01
Normal-vs-Stage2
4.257000E-01
Normal-vs-Stage3
3.057600E-01
Normal-vs-Stage4
4.281400E-01
Stage1-vs-Stage2
6.215000E-01
Stage1-vs-Stage3
8.766300E-02
Stage1-vs-Stage4
6.673400E-01
Stage2-vs-Stage3
1.934230E-01
Stage2-vs-Stage4
9.659000E-01
Stage3-vs-Stage4
1.494560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.245400E-01
Normal-vs-AfricanAmerican
4.233800E-01
Normal-vs-Asian
1.883230E-01
Caucasian-vs-AfricanAmerican
9.360800E-01
Caucasian-vs-Asian
9.911600E-01
AfricanAmerican-vs-Asian
9.572800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.035000E-01
Normal-vs-Female
4.537400E-01
Male-vs-Female
1.420180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.831400E-01
Normal-vs-Age(41-60Yrs)
4.789600E-01
Normal-vs-Age(61-80Yrs)
4.050800E-01
Normal-vs-Age(81-100Yrs)
3.921200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.641000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.611000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.458800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.805700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.309160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.079800E-01
Normal-vs-Daily Drinker
3.589800E-01
Normal-vs-Weekly Drinker
4.245600E-01
Normal-vs-Occasional Drinker
3.937800E-01
Normal-vs-Social Drinker
4.977600E-01
Non Drinker-vs-Daily Drinker
3.222600E-01
Non Drinker-vs-Weekly Drinker
8.517000E-01
Non Drinker-vs-Occasional Drinker
7.897800E-01
Non Drinker-vs-Social Drinker
2.399200E-01
Daily Drinker-vs-Weekly Drinker
3.434600E-01
Daily Drinker-vs-Occasional Drinker
4.409000E-01
Daily Drinker-vs-Social Drinker
5.533600E-02
Weekly Drinker-vs-Occasional Drinker
7.056600E-01
Weekly Drinker-vs-Social Drinker
4.509000E-01
Occasional Drinker-vs-Social Drinker
1.782630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.904400E-01
Normal-vs-Grade 2
7.505000E-01
Normal-vs-Grade 3
3.017200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.081000E-01
Grade 1-vs-Grade 3
6.280200E-01
Grade 1-vs-Grade 4
4.904400E-01
Grade 2-vs-Grade 3
3.564400E-01
Grade 2-vs-Grade 4
7.505000E-01
Grade 3-vs-Grade 4
3.017200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.876600E-01
Normal-vs-NonDiabetic
4.201200E-01
Diabetic-vs-NonDiabetic
3.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.170200E-01
Normal-vs-NoPancreatitis
4.102400E-01
Pancreatitis-vs-NoPancreatitis
9.956600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.283800E-01
Normal-vs-N1
4.249800E-01
N0-vs-N1
9.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.439400E-01
Normal-vs-TP53-NonMutant
4.762600E-01
TP53-Mutant-vs-TP53-NonMutant
5.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
